Since early 2020, the healthcare supply chain seemed to recoil from the just-in-time (JIT), modified stockless and stockless distribution methods that defined advanced, forward-thinking operations until they were tested by global supply chain challenges ignited by the COVID-19 pandemic.

By mid-2022, sensing – if not hoping for – an end to the pandemic and accepting COVID-19 as more endemic as influenza, the industry yearned to pivot to some kind of recovery mode, translating lessons learned to reshape how to handle future crises.

Atul Vashistha, CEO and Founder, Supply Wisdom in conversation with Rick Dana Barlow, Healthcare Purchasing News says “During the early days of the pandemic crisis, decision makers were forced to respond reactively without a clear or current view of the true health of their suppliers or supply chains.”

READ THE FULL ARTICLE HERE